Lv22
180 积分 2020-07-16 加入
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
1天前
已完结
Clinical application of circulating tumour DNA in colorectal cancer
2天前
已完结
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
5个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
5个月前
已完结
Efficacy and Safety of Recombinant Human Endostatin During Peri-Radiotherapy Period in Advanced Non-Small-Cell Lung Cancer
6个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
7个月前
已完结
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
7个月前
已完结
Efficacy and safety of recombinant human endostatin during peri-radiotherapy period in advanced non-small-cell lung cancer
7个月前
已完结
Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial
7个月前
已完结
皖公网安备34019202002308
